# A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

> **NCT03144635** · PHASE4 · COMPLETED · sponsor: **Kyushu University** · enrollment: 80 (actual)

## Conditions studied

- Hepatitis C Viral
- Chronic Kidney Disease stage3

## Interventions

- **DRUG:** Grazoprevir plus Elbasvir

## Key facts

- **NCT ID:** NCT03144635
- **Lead sponsor:** Kyushu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-09-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03144635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03144635, "A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03144635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*